🇰🇷 Valproate in South Korea

Valproate (Valproate) regulatory status in South Korea.

Marketing authorisations

MFDS

  • Status: likely_approved

MFDS

  • Status: likely_approved

MFDS

  • Status: likely_approved

Valproate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is Valproate approved in South Korea?

Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.

Who is the marketing authorisation holder for Valproate in South Korea?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is the originator. The local marketing authorisation holder may differ — check the official source linked above.